For example, the SSO Nusinersen that treats Spinal Muscular Atrophy targets the intron downstream of exon 7 in the SMN2 pre-mRNA, to block binding of the splicing repressor hnRNPA1 (Singh and Singh, 2018). This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.